Publication: 4371

Publication: 4371

Alliance A031501: AMBASSADOR study of Adjuvant Pembrolizumab (Pembro) in Muscle-Invasive Urothelial Carcinoma (MIUC) vs Observation (Obs): Extended follow-up results and metastatic disease recurrence distribution

DOI

URL

Google Scholar

Citation:: Annals of Oncology vol 35 (Supplement 2) S1135-S1136

Meeting Instance:: ESMO 2024
Year:: 2024
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Long-Term-Followup
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epreprint

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 4435

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Merck Sharp & Dohme Corp
Grants:: U10CA180821, U10CA180882; U10CA180820 (ECOG-ACRIN); U10CA180888 (SWOG);

Corr. Author:
Authors:: Andrea B. Apolo Karla V. Ballman Guru Sonpavde Stephanie Berg William Y. Kim Rahul Parikh Min Yuen Teo Randy F. Sweis Daniel Geynisman Petros Grivas Gurkamal Chatta Zachery Roger Reichert Joseph Woong Kim Mehmet Asim Bilen Bradley McGregor Sandy Srinivas Susan Halabi Gabriela Perez Burbano Michael J. Morris Jonathan E. Rosenberg

Networks:: FL086, KANSAS, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-NC007, LAPS-NY016, LAPS-NY158, MD001

Study: Alliance-A031501
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: